A Randomized, Double Blind, Placebo-controlled Phase II Study of KPS-0373 in Patients With SCD.
Phase of Trial: Phase II
Latest Information Update: 30 Nov 2012
At a glance
- Drugs Rovatirelin (Primary)
- Indications Spinocerebellar degeneration
- Focus Therapeutic Use
- 30 Nov 2012 Status changed from active, no longer recruiting to completed as reported by ClincialTrials.gov record.
- 12 Mar 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 01 Jul 2011 New trial record